Compositions and Methods of Inhibiting the Binding of Plasma IGG Autoantibodies to Serotonin 2A Receptor
Copyright © Targeted News Service 2024
2024-10-22
ALEXANDRIA, Virginia, Oct. 22 -- THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, District of Columbia has been assigned a patent (No. US 12122853 B2, initially filed March 4, 2022) developed by Mark B. Zimering, Lyons, New Jersey, for "Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor." . . .